Boothbay Fund Management’s VYNE Therapeutics VYNE Stock Holding History

Boothbay Fund Management’s Portfolio VYNE Stock Details VYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.6K	Hold	81,371	–	–	﹤0.01%	1928
2025 Q4	$47.2K	Sell	81,371 -25,088	-24%	-$10.1K	﹤0.01%	1827
2025 Q3	$35.7K	Hold	106,459	–	–	﹤0.01%	1804
2025 Q2	$176K	Buy	+106,459	New	+$138K	0.01%	1265
2020 Q3	–	Sell	-625	Closed	-$78K	–	1295
2020 Q2	$78K	Buy	+625	New	+$84.6K	0.01%	898
2018 Q4	–	Sell	-444	Closed	-$315K	–	967
2018 Q3	$315K	Buy	+444	New	+$274K	0.04%	487

Other funds holding VYNE

Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $704M AUM 37.47% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return

T3 Companies New York $73.3M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return